NL8801741A - Kunsthuid. - Google Patents

Kunsthuid. Download PDF

Info

Publication number: NL8801741A
Authority: NL; Netherlands
Prior art keywords: artificial skin; skin according; top layer; wound; bottom layer
Prior art date: 1988-07-08

Application number

NL8801741A

Other languages

English (en)

Dutch (nl)

Original Assignee

Utermoehlen Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-07-08

Filing date

1988-07-08

Publication date

1990-02-01

1988-07-08 Application filed by Utermoehlen Nv filed Critical Utermoehlen Nv

1988-07-08 Priority to NL8801741A priority Critical patent/NL8801741A/nl

1989-07-07 Priority to EP89201823A priority patent/EP0351016B1/fr

1989-07-07 Priority to US07/376,604 priority patent/US4985036A/en

1989-07-07 Priority to AT89201823T priority patent/ATE96295T1/de

1989-07-07 Priority to DE89201823T priority patent/DE68910206T2/de

1990-02-01 Publication of NL8801741A publication Critical patent/NL8801741A/nl

Links

239000011148 porous material Substances 0.000 claims abstract description 24
229920001971 elastomer Polymers 0.000 claims abstract description 8
239000000806 elastomer Substances 0.000 claims abstract 6
229920002635 polyurethane Polymers 0.000 claims description 25
239000004814 polyurethane Substances 0.000 claims description 25
239000002245 particle Substances 0.000 claims description 18
230000003619 fibrillary effect Effects 0.000 claims description 13
239000000758 substrate Substances 0.000 claims description 8
UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 5
239000004721 Polyphenylene oxide Substances 0.000 claims description 5
229920000570 polyether Polymers 0.000 claims description 5
-1 polytetramethylene adipate Polymers 0.000 claims description 5
239000004970 Chain extender Substances 0.000 claims description 4
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 4
239000011800 void material Substances 0.000 claims description 3
239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 2
RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 2
229920000728 polyester Polymers 0.000 claims description 2
229920001223 polyethylene glycol Polymers 0.000 claims description 2
DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims description 2
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims 2
239000002202 Polyethylene glycol Substances 0.000 claims 1
CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
239000000463 material Substances 0.000 abstract description 25
210000003491 skin Anatomy 0.000 description 131
206010052428 Wound Diseases 0.000 description 75
208000027418 Wounds and injury Diseases 0.000 description 71
239000003397 biobrane Substances 0.000 description 45
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
238000000034 method Methods 0.000 description 19
239000000243 solution Substances 0.000 description 19
230000001580 bacterial effect Effects 0.000 description 17
229920000642 polymer Polymers 0.000 description 17
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
239000012528 membrane Substances 0.000 description 13
CWEFIMQKSZFZNY-UHFFFAOYSA-N pentyl 2-[4-[[4-[4-[[4-[[4-(pentoxycarbonylamino)phenyl]methyl]phenyl]carbamoyloxy]butoxycarbonylamino]phenyl]methyl]phenyl]acetate Chemical compound C1=CC(CC(=O)OCCCCC)=CC=C1CC(C=C1)=CC=C1NC(=O)OCCCCOC(=O)NC(C=C1)=CC=C1CC1=CC=C(NC(=O)OCCCCC)C=C1 CWEFIMQKSZFZNY-UHFFFAOYSA-N 0.000 description 13
229920001817 Agar Polymers 0.000 description 12
239000008272 agar Substances 0.000 description 12
230000035515 penetration Effects 0.000 description 10
230000008569 process Effects 0.000 description 10
239000011521 glass Substances 0.000 description 9
239000000047 product Substances 0.000 description 9
150000003839 salts Chemical class 0.000 description 9
239000002904 solvent Substances 0.000 description 9
239000000725 suspension Substances 0.000 description 9
230000032258 transport Effects 0.000 description 9
230000007547 defect Effects 0.000 description 8
210000002615 epidermis Anatomy 0.000 description 8
230000035876 healing Effects 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
238000004626 scanning electron microscopy Methods 0.000 description 8
229960003600 silver sulfadiazine Drugs 0.000 description 8
UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
239000012530 fluid Substances 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
241000700198 Cavia Species 0.000 description 6
102000009123 Fibrin Human genes 0.000 description 6
108010073385 Fibrin Proteins 0.000 description 6
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
230000000844 anti-bacterial effect Effects 0.000 description 6
239000011248 coating agent Substances 0.000 description 6
238000000576 coating method Methods 0.000 description 6
239000013065 commercial product Substances 0.000 description 6
230000003247 decreasing effect Effects 0.000 description 6
238000001704 evaporation Methods 0.000 description 6
230000008020 evaporation Effects 0.000 description 6
229950003499 fibrin Drugs 0.000 description 6
238000005259 measurement Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
238000001556 precipitation Methods 0.000 description 6
238000012360 testing method Methods 0.000 description 6
230000029663 wound healing Effects 0.000 description 6
206010063560 Excessive granulation tissue Diseases 0.000 description 5
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 5
238000011109 contamination Methods 0.000 description 5
210000000416 exudates and transudate Anatomy 0.000 description 5
210000001126 granulation tissue Anatomy 0.000 description 5
229960002897 heparin Drugs 0.000 description 5
229920000669 heparin Polymers 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
229910001220 stainless steel Inorganic materials 0.000 description 5
239000010935 stainless steel Substances 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
241000589517 Pseudomonas aeruginosa Species 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000000694 effects Effects 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000009467 reduction Effects 0.000 description 4
229920000742 Cotton Polymers 0.000 description 3
206010072170 Skin wound Diseases 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
239000004599 antimicrobial Substances 0.000 description 3
WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 3
238000005345 coagulation Methods 0.000 description 3
230000015271 coagulation Effects 0.000 description 3
238000010276 construction Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
230000037311 normal skin Effects 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
229920002379 silicone rubber Polymers 0.000 description 3
239000001509 sodium citrate Substances 0.000 description 3
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
238000001966 tensiometry Methods 0.000 description 3
150000003673 urethanes Chemical class 0.000 description 3
208000035143 Bacterial infection Diseases 0.000 description 2
RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
206010057249 Phagocytosis Diseases 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
230000008952 bacterial invasion Effects 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
230000008602 contraction Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
230000002706 hydrostatic effect Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
230000035699 permeability Effects 0.000 description 2
230000008782 phagocytosis Effects 0.000 description 2
238000005191 phase separation Methods 0.000 description 2
239000002861 polymer material Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
239000012925 reference material Substances 0.000 description 2
239000005060 rubber Substances 0.000 description 2
231100000241 scar Toxicity 0.000 description 2
239000004945 silicone rubber Substances 0.000 description 2
238000005507 spraying Methods 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
210000003708 urethra Anatomy 0.000 description 2
PMDHMYFSRFZGIO-UHFFFAOYSA-N 1,4,7-trioxacyclotridecane-8,13-dione Chemical compound O=C1CCCCC(=O)OCCOCCO1 PMDHMYFSRFZGIO-UHFFFAOYSA-N 0.000 description 1
DSUFPYCILZXJFF-UHFFFAOYSA-N 4-[[4-[[4-(pentoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamoyloxy]butyl n-[4-[[4-(butoxycarbonylamino)cyclohexyl]methyl]cyclohexyl]carbamate Chemical compound C1CC(NC(=O)OCCCCC)CCC1CC1CCC(NC(=O)OCCCCOC(=O)NC2CCC(CC3CCC(CC3)NC(=O)OCCCC)CC2)CC1 DSUFPYCILZXJFF-UHFFFAOYSA-N 0.000 description 1
VLGDSNWNOFYURG-UHFFFAOYSA-N 4-propyloxetan-2-one Chemical compound CCCC1CC(=O)O1 VLGDSNWNOFYURG-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
239000004830 Super Glue Substances 0.000 description 1
208000033809 Suppuration Diseases 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
206010048038 Wound infection Diseases 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
239000011358 absorbing material Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000003915 air pollution Methods 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000001982 cetrimide agar Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000008094 contradictory effect Effects 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
239000006071 cream Substances 0.000 description 1
230000012969 defense response to bacterium Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
229940106012 diethylene glycol adipate Drugs 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
FZWBABZIGXEXES-UHFFFAOYSA-N ethane-1,2-diol;hexanedioic acid Chemical compound OCCO.OC(=O)CCCCC(O)=O FZWBABZIGXEXES-UHFFFAOYSA-N 0.000 description 1
FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
GJIDOLBZYSCZRX-UHFFFAOYSA-N hydroxymethyl prop-2-enoate Chemical compound OCOC(=O)C=C GJIDOLBZYSCZRX-UHFFFAOYSA-N 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
230000001788 irregular Effects 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000003562 morphometric effect Effects 0.000 description 1
238000013425 morphometry Methods 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
238000010606 normalization Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920006255 plastic film Polymers 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
238000000710 polymer precipitation Methods 0.000 description 1
229920006264 polyurethane film Polymers 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000009993 protective function Effects 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
210000001243 pseudopodia Anatomy 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
210000001635 urinary tract Anatomy 0.000 description 1
230000010388 wound contraction Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
- A61F2/105—Skin implants, e.g. artificial skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00182—Wound bandages with transparent part
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00221—Wound bandages not adhering to the wound biodegradable, non-irritating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00251—Wound bandages in a special way pervious to air or vapours with macroscopic openings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00255—Wound bandages in a special way pervious to air or vapours with pores
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00259—Wound bandages in a special way pervious to air or vapours thin film
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00263—Wound bandages in a special way pervious to air or vapours vapour permeability >500 g/m2/24h
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00293—Wound bandages anallergic or hypoallergic material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
- A61F2013/00527—Plasters use for treating burn artificial skin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Dispersion Chemistry (AREA)
Medicinal Chemistry (AREA)
Materials For Medical Uses (AREA)
Laminated Bodies (AREA)

NL8801741A 1988-07-08 1988-07-08 Kunsthuid. NL8801741A (nl)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
NL8801741A NL8801741A (nl)	1988-07-08	1988-07-08	Kunsthuid.
EP89201823A EP0351016B1 (fr)	1988-07-08	1989-07-07	Peau artificielle
US07/376,604 US4985036A (en)	1988-07-08	1989-07-07	Artificial skin
AT89201823T ATE96295T1 (de)	1988-07-08	1989-07-07	Kunsthaut.
DE89201823T DE68910206T2 (de)	1988-07-08	1989-07-07	Kunsthaut.

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8801741		1988-07-08
NL8801741A NL8801741A (nl)	1988-07-08	1988-07-08	Kunsthuid.

Publications (1)

Publication Number	Publication Date
NL8801741A true NL8801741A (nl)	1990-02-01

Family

ID=19852597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8801741A NL8801741A (nl)	1988-07-08	1988-07-08	Kunsthuid.

Country Status (5)

Country	Link
US (1)	US4985036A (fr)
EP (1)	EP0351016B1 (fr)
AT (1)	ATE96295T1 (fr)
DE (1)	DE68910206T2 (fr)
NL (1)	NL8801741A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8902237A (nl) *	1989-09-06	1991-04-02	Hc Implants Bv	Kunsthuid.
NL9001156A (nl) *	1990-05-17	1991-12-16	Utermoehlen Nv	Wondbedekker alsmede werkwijze voor het vervaardigen daarvan.
IT1248934B (it) *	1990-06-01	1995-02-11	Fidia Spa	Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US6280771B1 (en)	1997-02-20	2001-08-28	Therics, Inc.	Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5490962A (en)	1993-10-18	1996-02-13	Massachusetts Institute Of Technology	Preparation of medical devices by solid free-form fabrication methods
AU695706B2 (en) *	1993-11-04	1998-08-20	Smith & Nephew Plc	Bandages
DE4426315C1 (de) *	1994-07-25	1996-03-21	Gore W L & Ass Gmbh	Membran zur Regeneration von Körpergeweben und Verwendung der Membran als Wundabdeckung und Hautersatz
US20030114936A1 (en) *	1998-10-12	2003-06-19	Therics, Inc.	Complex three-dimensional composite scaffold resistant to delimination
AU768641B2 (en)	1998-10-12	2003-12-18	Massachusetts Institute Of Technology	Composites for tissue regeneration and methods of manufacture thereof
JP2000167039A (ja) *	1998-11-30	2000-06-20	Isotis Bv	人造皮膚
ATE504262T1 (de) *	2002-07-17	2011-04-15	Proxy Biomedical Ltd	Membrane für medizinische implantation
KR100773247B1 (ko) *	2005-04-20	2007-11-05	주식회사 엘지화학	향상된 과충전 안전성의 리튬 이차전지
WO2007070141A1 (fr) *	2005-09-12	2007-06-21	Proxy Biomedical Limited	Implants de partie molle et procede de fabrication
EP2049041A1 (fr) *	2006-08-10	2009-04-22	AO Technology AG	Matériau polymère biomédical pour réparation et réalisation de tissu
US20090234305A1 (en) *	2008-03-15	2009-09-17	Ernest Aubrey Woodroof	Temporary skin substitute comprised of biological compounds of plant and animal origins
RU2014128792A (ru)	2011-12-15	2016-02-10	Колгейт-Палмолив Компани	Очищающие композиции с полиуретаном-34
CN103948960B (zh) *	2014-05-20	2016-01-13	四川大学	一种含纳米银多孔硅橡胶/聚氨酯双层人工皮肤及其制备方法
CN113663134B (zh) *	2021-08-27	2023-02-28	苏州诺普再生医学有限公司	仿生皮肤支架及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2093703B (en) *	1981-02-13	1985-08-07	Smith & Nephew Ass	Wound dressings for burns
DE3302984C2 (de) *	1983-01-29	1986-05-22	Sorbexx GmbH Gesellschaft für Adsorptionstechnik und Verbundstoffe, 8586 Gefrees	Wundabdeckmaterial in Bahnform
JPS60261460A (ja) *	1984-06-11	1985-12-24	株式会社　高研	コラ−ゲンとポリ―α―アミノ酸膜から成る人工皮膚
GB2170713B (en) *	1985-02-13	1988-10-05	Tpo Pharmachim	Human skin substitute for temporary use
DE3682734D1 (de) *	1985-08-23	1992-01-16	Kanegafuchi Chemical Ind	Kuenstliches gefaess.
US4704130A (en) *	1985-10-18	1987-11-03	Mitral Medical, International, Inc.	Biocompatible microporous polymeric materials and methods of making same
US4822352A (en) *	1986-08-08	1989-04-18	Ube Industries, Ltd.	Medical tubes with porous textured walls
EP0265906B1 (fr) *	1986-10-31	1995-04-19	Nippon Zeon Co., Ltd.	Pansement
US4947840A (en) *	1987-08-21	1990-08-14	Massachusetts Institute Of Technology	Biodegradable templates for the regeneration of tissues

1988
- 1988-07-08 NL NL8801741A patent/NL8801741A/nl not_active Application Discontinuation
1989
- 1989-07-07 EP EP89201823A patent/EP0351016B1/fr not_active Expired - Lifetime
- 1989-07-07 AT AT89201823T patent/ATE96295T1/de active
- 1989-07-07 DE DE89201823T patent/DE68910206T2/de not_active Expired - Fee Related
- 1989-07-07 US US07/376,604 patent/US4985036A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0351016A3 (fr)	1991-01-02
ATE96295T1 (de)	1993-11-15
US4985036A (en)	1991-01-15
DE68910206D1 (de)	1993-12-02
EP0351016B1 (fr)	1993-10-27
EP0351016A2 (fr)	1990-01-17
DE68910206T2 (de)	1994-05-11

Legal Events

Date	Code	Title	Description
1990-02-01	A1B	A search report has been drawn up
1990-05-01	AK	Correction of former applications already laid open	Free format text: IN PAT.BUL.03/90,PAGES 291,293 AND 302: THE MAIN CLASSIFICATION A61L 15/01 CORR. A61L 15/22
1991-03-01	BV	The patent application has lapsed

Publication	Publication Date	Title
NL8801741A (nl)	1990-02-01	Kunsthuid.
He et al.	2020	Anti-oxidant electroactive and antibacterial nanofibrous wound dressings based on poly (ε-caprolactone)/quaternized chitosan-graft-polyaniline for full-thickness skin wound healing
Han et al.	2014	Preparation, characteristics and assessment of a novel gelatin–chitosan sponge scaffold as skin tissue engineering material
Choi et al.	2001	Studies on gelatin-based sponges. Part III: A comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat
Sun et al.	2014	bFGF-grafted electrospun fibrous scaffolds via poly (dopamine) for skin wound healing
Khampieng et al.	2018	Silver nanoparticles-based hydrogel: Characterization of material parameters for pressure ulcer dressing applications
Gupta et al.	2010	Textile-based smart wound dressings
Vargas et al.	2010	Hyperbranched polyglycerol electrospun nanofibers for wound dressing applications
Beumer et al.	1993	Cell-seeding and in vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA
Wang et al.	2012	Polyurethane for biomedical applications: A review of recent developments
Lee et al.	2003	Effect of topically applied silver sulfadiazine on fibroblast cell proliferation and biomechanical properties of the wound
JPH08294530A (ja)	1996-11-12	心臓血管修復材及びその製造方法
WO1992019194A1 (fr)	1992-11-12	Matiere pour pansement
CN107519524B (zh)	2024-07-19	一种聚己内酯/胶原蛋白/季铵盐静电纺丝复合纤维膜及其制备方法
CN107617126A (zh)	2018-01-23	一种多孔材料的表面修饰方法及应用
JP2002523565A (ja)	2002-07-30	本来的に抗菌性の第４級アミンヒドロゲル創傷ドレッシング
Dias et al.	2019	Soybean-modified polyamide-6 mats as a long-term cutaneous wound covering
Al-Hammood et al.	2025	Deferoxamine-loaded trilayer scaffold containing propolis and sulfated polysaccharides promotes in vivo wound healing through angiogenesis stimulation
Ionescu et al.	2021	Acrylate-endcapped urethane-based hydrogels: An in vivo study on wound healing potential
Beumer et al.	1993	A new biodegradable matrix as part of a cell seeded skin substitute for the treatment of deep skin defects: a physico-chemical characterisation
Tottoli et al.	2022	BioFiber: An advanced fibrous textured dressing to manage exudate in severe wounds
Hautmann et al.	2024	Design of a composite wound dressing: combining an electrospun fleece with a free-standing multilayer film
Contreras-García et al.	2011	Stimuli–responsive networks grafted onto polypropylene for the sustained delivery of NSAIDs
Van Luyn et al.	1992	Cytotoxicity testing of wound dressings using methylcellulose cell culture
Fan et al.	2022	Cellulose acetate/Plerixafor wound dressings for transplantation of menstrual blood stem cells: Potential treatment modality for diabetic wounds